MLB investigating doping report involving top players

Tue Jan 29, 2013 8:34pm EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

By Julian Linden

(Reuters) - Major League Baseball (MLB) said on Tuesday it was investigating a report alleging several high-profile players were sold performance-enhancing drugs by a South Florida anti-aging clinic.

MLB said in a statement it was "extremely disappointed" to hear any alleged links between players and banned drugs but was investigating the claims, published in the Miami New Times on Tuesday.

"We remain fully committed to following all leads and seeking the appropriate outcomes for all those who use, purchase and are involved in the distribution of banned substances, which have no place in our game," MLB said.

"We are in the midst of an active investigation and are gathering and reviewing information. We will refrain from further comment until this process is complete."

The New Times, a free weekly newspaper published in Miami, identified several players that it said had allegedly been sold human growth hormone, testosterone and anabolic steroids by the clinic's head, named as Anthony Bosch.

The newspaper said a former employee of the clinic, which is now closed, had provided handwritten medical records from the clinic that showed links between the players and banned drugs.

Two of the players named in the report, New York Yankees third baseman Alex Rodriguez and Washington Nationals starting pitcher Gio Gonzalez, have denied the allegations.

"The news report about a purported relationship between Alex Rodriguez and Anthony Bosch are not true. Alex Rodriguez was not Mr. Bosch's patient, he was never treated by him and he was never advised by him," Rodriguez said in a statement released by his publicist.   Continued...

New York Yankees' Alex Rodriguez awaits his turn in the batting cage prior to their MLB American League baseball game against the Oakland Athletics in Oakland, California July 7, 2010. REUTERS/Robert Galbraith